FI954876A - Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi - Google Patents
Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi Download PDFInfo
- Publication number
- FI954876A FI954876A FI954876A FI954876A FI954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A
- Authority
- FI
- Finland
- Prior art keywords
- quantification
- detection
- multiple sclerosis
- factor associated
- cytotoxic factor
- Prior art date
Links
- 239000003145 cytotoxic factor Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 201000006417 multiple sclerosis Diseases 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
- 210000003963 intermediate filament Anatomy 0.000 abstract 3
- 230000015556 catabolic process Effects 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 210000001130 astrocyte Anatomy 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 230000003583 cytomorphological effect Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 231100000424 gliotoxic Toxicity 0.000 abstract 1
- 230000001509 gliotoxic effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/16—Dendrimers and dendritic polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/827—Lectins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/828—Protein A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9401946A FR2716198B1 (fr) | 1994-02-15 | 1994-02-15 | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. |
PCT/FR1995/000178 WO1995021859A1 (fr) | 1994-02-15 | 1995-02-15 | Facteur cytotoxique tel qu'associe a la sclerose en plaques, sa detection et sa quantification |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954876A0 FI954876A0 (fi) | 1995-10-13 |
FI954876A true FI954876A (fi) | 1995-10-13 |
Family
ID=9460272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954876A FI954876A (fi) | 1994-02-15 | 1995-10-13 | Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi |
Country Status (13)
Country | Link |
---|---|
US (2) | US5876954A (fi) |
EP (1) | EP0667354B1 (fi) |
JP (1) | JP2803910B2 (fi) |
AT (1) | ATE205856T1 (fi) |
AU (1) | AU701972B2 (fi) |
CA (1) | CA2142557C (fi) |
DE (1) | DE69522725T2 (fi) |
DK (1) | DK0667354T3 (fi) |
FI (1) | FI954876A (fi) |
FR (1) | FR2716198B1 (fi) |
NO (1) | NO954081L (fi) |
NZ (1) | NZ281260A (fi) |
WO (1) | WO1995021859A1 (fi) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2233936T3 (es) | 1994-02-04 | 2005-06-16 | Bio Merieux | Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones. |
US6284236B1 (en) | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
FR2745974B1 (fr) * | 1996-03-14 | 1998-04-17 | Animal modifie, utilisations et procede pour mesurer l'efficacite d'un procede therapeutique | |
DK0925504T3 (da) * | 1996-09-12 | 2001-07-23 | Bio Merieux | Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor |
ATE440141T1 (de) | 1996-11-26 | 2009-09-15 | Bio Merieux | Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen |
FR2765588A1 (fr) | 1997-07-07 | 1999-01-08 | Bio Merieux | Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques |
FR2797402B1 (fr) * | 1999-07-15 | 2004-03-12 | Biomerieux Stelhys | Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191327A (en) * | 1978-08-24 | 1981-07-13 | W B Martin | Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica |
US4311686A (en) * | 1979-04-30 | 1982-01-19 | The Immunology Development Corporation | Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis |
US4396600A (en) * | 1980-12-18 | 1983-08-02 | Gus Gallucci | Adult schistosome worm-derived antigenic substance and method of obtaining same |
US4388298A (en) * | 1982-07-14 | 1983-06-14 | The United States Of America As Represented By The Secretary Of Agriculture | Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced |
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
US4647773A (en) * | 1984-04-23 | 1987-03-03 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS |
US4520113A (en) * | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
NZ218050A (en) * | 1985-11-13 | 1989-05-29 | Wistar Inst | Test for the presence of htlv-1v |
US4900553A (en) * | 1987-09-11 | 1990-02-13 | Case Western Reserve University | Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
EP0326395A2 (en) * | 1988-01-29 | 1989-08-02 | City Of Hope | Method of detecting and identifying certain viral sequences |
FR2651581B1 (fr) * | 1989-09-06 | 1994-05-13 | Centre Nal Recherc Scientifique | Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques. |
US5219837A (en) * | 1990-06-21 | 1993-06-15 | Trustees Of The University Of Pennsylvania | Method of stimulating myelination of cells |
US5158976A (en) * | 1990-10-29 | 1992-10-27 | The Children's Medical Center Corporation | Controlling glutamine/glutamate related neuronal injury |
DK173091D0 (da) * | 1991-10-11 | 1991-10-11 | Schleroseforeningen The Danish | Biologisk materiale |
FR2689520B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques. |
FR2689521B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture. |
WO1993023550A2 (en) * | 1992-05-18 | 1993-11-25 | Genentech, Inc. | Activation of oligomerizing receptors by using fused receptor ligands |
GB9310657D0 (en) * | 1993-05-24 | 1993-07-07 | Univ London | Retrovirus |
-
1994
- 1994-02-15 FR FR9401946A patent/FR2716198B1/fr not_active Expired - Fee Related
-
1995
- 1995-02-15 DK DK95420031T patent/DK0667354T3/da active
- 1995-02-15 DE DE69522725T patent/DE69522725T2/de not_active Expired - Fee Related
- 1995-02-15 EP EP95420031A patent/EP0667354B1/fr not_active Expired - Lifetime
- 1995-02-15 AT AT95420031T patent/ATE205856T1/de not_active IP Right Cessation
- 1995-02-15 JP JP7521024A patent/JP2803910B2/ja not_active Expired - Fee Related
- 1995-02-15 AU AU18152/95A patent/AU701972B2/en not_active Ceased
- 1995-02-15 WO PCT/FR1995/000178 patent/WO1995021859A1/fr active Application Filing
- 1995-02-15 US US08/389,164 patent/US5876954A/en not_active Expired - Fee Related
- 1995-02-15 NZ NZ281260A patent/NZ281260A/en unknown
- 1995-02-15 CA CA002142557A patent/CA2142557C/fr not_active Expired - Fee Related
- 1995-06-06 US US08/468,670 patent/US5728540A/en not_active Expired - Fee Related
- 1995-10-13 NO NO954081A patent/NO954081L/no not_active Application Discontinuation
- 1995-10-13 FI FI954876A patent/FI954876A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
US5876954A (en) | 1999-03-02 |
FI954876A0 (fi) | 1995-10-13 |
DK0667354T3 (da) | 2002-01-14 |
JP2803910B2 (ja) | 1998-09-24 |
DE69522725T2 (de) | 2002-07-04 |
US5728540A (en) | 1998-03-17 |
AU1815295A (en) | 1995-08-29 |
DE69522725D1 (de) | 2001-10-25 |
JPH08511808A (ja) | 1996-12-10 |
WO1995021859A1 (fr) | 1995-08-17 |
NO954081D0 (no) | 1995-10-13 |
EP0667354A1 (fr) | 1995-08-16 |
NZ281260A (en) | 1998-05-27 |
CA2142557A1 (fr) | 1995-08-16 |
EP0667354B1 (fr) | 2001-09-19 |
CA2142557C (fr) | 2001-11-20 |
ATE205856T1 (de) | 2001-10-15 |
NO954081L (no) | 1995-12-13 |
FR2716198B1 (fr) | 1996-04-19 |
AU701972B2 (en) | 1999-02-11 |
FR2716198A1 (fr) | 1995-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI940326A0 (it) | Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica | |
FI943718A0 (fi) | Piperatsiini- ja piperadiinijohdannaisia ja niiden käyttö antipsykoottisina aineina | |
IT1229195B (it) | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. | |
ATE265997T1 (de) | Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität | |
ITMI931518A0 (it) | Derivati eparinici ad attivita' antimetastatica | |
BR9711586A (pt) | Compostos e uso dos mesmo | |
DE69228492D1 (de) | 3,4,N-Trisubstituierte-4,5-dihydro-1H-Pyrazol-1-carboxamide und deren Anwendung als Insektizide | |
FI930070A0 (fi) | Hiv-inhiberande benzenacetamidderivat | |
FI932074A (fi) | Anordning foer att i en bearbetningsanlaeggning transportera och positionera foerdelaktigt laongstraeckta arbetsstycken, saerskilt arbetsstycken av trae | |
FI954876A (fi) | Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi | |
TR28830A (tr) | Insektisid özellikte N'-sübstitüe edilmis N,N`- diacilhidrazinler. | |
DE68900210D1 (de) | Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen. | |
NO932502L (no) | Nye fosfolipidderivater | |
FR2682457B1 (fr) | Feu d'avertissement tournant, du type gyrophare. | |
ITMI911834A1 (it) | Falciatrice o rispettivamente trinciapaglia | |
FI934468A0 (fi) | Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter | |
FR2671794B1 (fr) | Verre d'ophtalmologie tres resistant aux acides. | |
DE69016196D1 (de) | Propanolderivate und diese enthaltende Duftstoffe. | |
ITMI912422A1 (it) | Derivati ossimici ad attivita' fungicida | |
FI950303A (fi) | Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina | |
FI945561A0 (fi) | Triatyyliboraanijohdannaisia, niiden valmistus ja niiden käyttö synteesivälituotteina | |
FI932595A (fi) | En vattenhaltig, polymerisk, viskositet upphoejande komposition | |
ATE126981T1 (de) | Aufhängungshalterung und diese enthaltende aufhängungsanordnung. | |
ITMI922071A0 (it) | Derivati xantonici, loro preparazione ed attivita' | |
FR2702768B1 (fr) | Nouveaux mono-amides de la Carpaïne, leur préparation et leur application en tant que médicaments. |